Zomedica Corp. (ZOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.0410
-0.0007 (-1.68%)
Aug 25, 2025, 9:30 AM EDT
Zomedica Market Cap
Zomedica has a market cap or net worth of $41.01 million as of August 25, 2025. Its market cap has decreased by -71.55% in one year.
Market Cap
41.01M
Enterprise Value
-14.54M
Revenue
28.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since July 29, 2016, Zomedica's market cap has decreased from 65.86M to 41.01M, a decrease of -37.73%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 41.01M | -65.13% |
| Dec 31, 2024 | 117.59M | -40.06% |
| Dec 29, 2023 | 196.19M | 22.82% |
| Dec 30, 2022 | 159.73M | -46.82% |
| Dec 31, 2021 | 300.34M | 130.90% |
| Dec 31, 2020 | 130.07M | 263.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |